Chemed Corp (CHE) Financials
CHE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 1.7 billion | 544.1 million |
| 2023-12-31 | 1.8 billion | 652.9 million |
| 2023-09-30 | 1.6 billion | 542.8 million |
| 2023-06-30 | 1.5 billion | 553.1 million |
CHE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 72.4 million | 9.0 million |
| 2023-12-31 | 96.8 million | 7.7 million |
| 2023-09-30 | 17.3 million | 8.6 million |
| 2023-06-30 | 115.9 million | 1.8 million |
CHE Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 65.0 million |
| 2023-12-31 | 90.1 million |
| 2023-09-30 | 75.0 million |
| 2023-06-30 | 53.4 million |
CHE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 313.4 million | - | 146.1 million |
| 2023-12-31 | 264.0 million | - | 139.4 million |
| 2023-09-30 | 173.2 million | - | 137.0 million |
| 2023-06-30 | 159.9 million | - | 140.9 million |
CHE Shares Outstanding
CHE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 12.2 million | - | 115.9 million | - |
| 2023-12-31 | 11.8 million | - | 105.9 million | -5.4 million |
| 2023-09-30 | 11.7 million | - | 95.3 million | - |
| 2023-06-30 | 16.4 million | - | 95.0 million | - |
CHE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 589.2 million | 400.9 million |
| 2023-12-31 | 585.9 million | 373.9 million |
| 2023-09-30 | 564.5 million | 362.4 million |
| 2023-06-30 | 553.8 million | 374.2 million |
CHE
List: Contenders
Price: $560.13
Dividend Yield: 0.28%
Forward Dividend Yield: 0.29%
Payout Ratio: 8.92%
Dividend Per Share: 1.60 USD
Earnings Per Share: 17.94 USD
P/E Ratio: 36.75
Exchange: NYQ
Sector: Healthcare
Industry: Medical Care Facilities
Volume: 83400
Ebitda: 68.2 millionMarket Capitalization: 8.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 40
DGR3: 5.57%
DGR5: 5.92%
DGR10: 7.19%